A novel POLH mutation causes XPV disease and XPV tumor proneness may involve imbalance of numerous DNA polymerases

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.6, Iss.6, 2013-01, pp. : 1583-1590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tumor‐associated DNA mutation detection in individuals undergoing colonoscopy

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 167-174

John Wiley & Sons Inc

Access to resources Recommend Favorite

Repair and Translesion DNA Polymerases as Anticancer Drug Targets

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 431-447

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Germline Mutation of the PTEN/MMAC1 Gene in a Patient with Cowden Disease

By Sanson Marc Zhou Xiao-Ping Brault Jean-Luc Hoang-Xuan Khê Hamelin Richard

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 973-975

Informa Healthcare

Access to resources Recommend Favorite

Differential Inhibition of Mammalian DNA Polymerases by X-irradiated DNA

By Nakamura H. Morita T. Yoshida S.

International Journal of Radiation Biology, Vol. 38, Iss. 4, 1980-10 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation causes tumor growth delay

By Amano Morikazu Suzuki Minoru Andoh Satoshi Monzen Hajime Terai Kaoru Williams Brent Song Chang W. Mayo Kevin H. Hasegawa Takeo Dings Ruud P.M. Griffin Robert J.

International Journal of Clinical Oncology, Vol. 12, Iss. 1, 2007-02 ,pp. : 42-47

Springer Publishing Company

Access to resources Recommend Favorite